Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?

被引:408
|
作者
Johnstone, RW
Licht, JD
机构
[1] Mt Sinai Sch Med, New York, NY 10029 USA
[2] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia
关键词
D O I
10.1016/S1535-6108(03)00165-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:13 / 18
页数:6
相关论文
共 50 条
  • [1] Histone deacetylase as a target for cancer therapy
    La Thangue, N
    Brown, R
    Finn, P
    Williams, R
    BRITISH JOURNAL OF CANCER, 2002, 86 : S9 - S10
  • [2] Histone deacetylase inhibitors in cancer therapy
    Lee, Min-Jung
    Kim, Yeong Sang
    Kummar, Shivaani
    Giaccone, Giuseppe
    Trepel, Jane B.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 639 - 649
  • [3] Histone deacetylase inhibitors in cancer therapy
    Fouladi, Maryam
    CANCER INVESTIGATION, 2006, 24 (05) : 521 - 527
  • [4] Histone Deacetylase Inhibitors in Cancer Therapy
    Lane, Andrew A.
    Chabner, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5459 - 5468
  • [5] Histone deacetylase inhibitors in cancer therapy
    Rosato, RR
    Grant, S
    CANCER BIOLOGY & THERAPY, 2003, 2 (01) : 30 - 37
  • [6] Histone Deacetylase Inhibitors for Cancer Therapy
    Kim, Tae-You
    Bang, Yung-Jue
    Robertson, Keith D.
    EPIGENETICS, 2006, 1 (01) : 14 - 23
  • [7] Histone Deacetylase Inhibitors in Cancer Therapy
    Sun, Yijie
    Sun, Yanyi
    Yue, Saichao
    Wang, Yaohe
    Lu, Fanghui
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (28) : 2420 - 2428
  • [8] HISTONE DEACETYLASE INHIBITORS FOR CANCER THERAPY
    Carlo-Stella, C.
    HAEMATOLOGICA, 2008, 93 : S12 - S13
  • [9] Histone deacetylase inhibitors in cancer therapy
    Rasheed, Walid K.
    Johnstone, Ricky W.
    Prince, H. Miles
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (05) : 659 - 678
  • [10] Histone deacetylase inhibitors and cancer therapy
    La Thangue, NB
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 64 - 67